Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-17-000982

COO, CLO, and Secretary gave up 21,667 shares (to pay taxes)

  • COO, CLO, and Secretary acquired 94,350 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BELBEL CAESAR J COO, CLO, and Secretary 2016-12-30 Grant or award +94,350 211,884 D
BELBEL CAESAR J COO, CLO, and Secretary 2016-12-31 Shares withheld for taxes −21,667 $5.35 $115,918 190,217 D
Loading xslF345X03/doc4.xml…